Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Laufkötter

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Data in Brief|September 9, 2020
Kinase inhibitor data set for systematic analysis of representative kinases across the human kinomeOliver Laufkötter, Stefan Laufer, Jürgen Bajorath
European Journal of Medicinal Chemistry|August 4, 2020
Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target relationshipsOliver Laufkötter, Stefan Laufer, Jürgen Bajorath
ACS Omega|September 26, 2019
Large-Scale Comparison of Alternative Similarity Search Strategies with Varying Chemical Information ContentsOliver Laufkötter, Tomoyuki Miyao, Jürgen Bajorath
Molecules (Basel, Switzerland)|August 12, 2023
Systematic Analysis of Covalent and Allosteric Protein Kinase InhibitorsElena Xerxa, Oliver Laufkötter, Jürgen Bajorath
European Journal of Medicinal Chemistry|February 4, 2021
Systematic comparison of competitive and allosteric kinase inhibitors reveals common structural characteristicsHuabin Hu, Oliver Laufkötter, Filip Miljković, et al.
Journal of Medicinal Chemistry|January 21, 2021
Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related CompoundsOliver Laufkötter, Huabin Hu, Filip Miljković, et al.
Data in Brief|February 19, 2021
Data set of competitive and allosteric protein kinase inhibitors confirmed by X-ray crystallographyHuabin Hu, Oliver Laufkötter, Filip Miljković, et al.
Journal of Cheminformatics|August 10, 2019
Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capabilityOliver Laufkötter, Noé Sturm, Jürgen Bajorath, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 13, 2024
Identification of cell type-specific cell-penetrating peptides through in vivo phage display leveraged by next generation sequencingFranziska Kohl, Oliver Laufkötter, Mike Firth, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Data in Brief|September 9, 2020
Kinase inhibitor data set for systematic analysis of representative kinases across the human kinomeOliver Laufkötter, Stefan Laufer, Jürgen Bajorath
European Journal of Medicinal Chemistry|August 4, 2020
Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target relationshipsOliver Laufkötter, Stefan Laufer, Jürgen Bajorath
ACS Omega|September 26, 2019
Large-Scale Comparison of Alternative Similarity Search Strategies with Varying Chemical Information ContentsOliver Laufkötter, Tomoyuki Miyao, Jürgen Bajorath
Molecules (Basel, Switzerland)|August 12, 2023
Systematic Analysis of Covalent and Allosteric Protein Kinase InhibitorsElena Xerxa, Oliver Laufkötter, Jürgen Bajorath
European Journal of Medicinal Chemistry|February 4, 2021
Systematic comparison of competitive and allosteric kinase inhibitors reveals common structural characteristicsHuabin Hu, Oliver Laufkötter, Filip Miljković, et al.
Journal of Medicinal Chemistry|January 21, 2021
Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related CompoundsOliver Laufkötter, Huabin Hu, Filip Miljković, et al.
Data in Brief|February 19, 2021
Data set of competitive and allosteric protein kinase inhibitors confirmed by X-ray crystallographyHuabin Hu, Oliver Laufkötter, Filip Miljković, et al.
Journal of Cheminformatics|August 10, 2019
Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capabilityOliver Laufkötter, Noé Sturm, Jürgen Bajorath, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 13, 2024
Identification of cell type-specific cell-penetrating peptides through in vivo phage display leveraged by next generation sequencingFranziska Kohl, Oliver Laufkötter, Mike Firth, et al.
Pageof 1